TOBREX (tobramycin)
KERATOCONJUNCTIVITIS·+5
Alcon Laboratories
Indication
Keratoconjunctivitis
Keratoconjunctivitis is an inflammatory condition affecting the ocular surface, characterized by concurrent inflammation of both the cornea and the conjunctiva. Read more about Keratoconjunctivitis
27 drugs 19 manufacturers
Drugs that treat it
Common Keratoconjunctivitis therapies.
TOBRAMYCIN
OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
SANDOZ
TOBRAMYCIN
KERATOCONJUNCTIVITIS·+5
AKORN INC.
TOBRAMYCIN
OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
BAUSCH & LOMB P
TOBREX (tobramycin)
KERATOCONJUNCTIVITIS·+5
ALCON/NOVARTIS
TOBREX (tobramycin)
KERATOCONJUNCTIVITIS·+5
ALCON/NOVARTIS
TOBRAMYCIN
KERATOCONJUNCTIVITIS·+5
SOMERSET PHARM
TOBRAMYCIN
KERATOCONJUNCTIVITIS·+5
Bausch Health US
TOBRAMYCIN
OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
ALEMBIC PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Keratoconjunctivitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonKeratoconjunctivitis is an inflammatory condition affecting the ocular surface, characterized by concurrent inflammation of both the cornea and the conjunctiva.
It can affect individuals of any age and arises from diverse etiologies, including viral or bacterial infections, severe allergic immune responses, tear film deficiencies, autoimmune diseases, and toxic or mechanical irritation.
Clinically and pathophysiologically, it features conjunctival hyperemia, chemosis, ocular pain, foreign-body sensation, and photophobia, accompanied by corneal epithelial disruption ranging from superficial punctate keratitis to stromal ulceration or subepithelial infiltrates that can impair visual acuity.
- nih.gov
Keratoconjunctivitis is an inflammatory condition affecting the ocular surface, characterized by concurrent inflammation of both the cornea and the conjunctiva It can affect individuals of any age and arises from diverse etiologies, including viral or bacterial infections, severe allergic immune responses, tear film deficiencies, autoimmune diseases, and toxic or mechanical irritation Clinically and pathophysiologically, it features conjunctival hyperemia, chemosis, ocular pain, foreign-body sen...
- nih.gov
It can affect individuals of any age and arises from diverse etiologies, including viral or bacterial infections, severe allergic immune responses, tear film deficiencies, autoimmune diseases, and toxic or mechanical irritation
- nih.gov
Clinically and pathophysiologically, it features conjunctival hyperemia, chemosis, ocular pain, foreign-body sensation, and photophobia, accompanied by corneal epithelial disruption ranging from superficial punctate keratitis to stromal ulceration or subepithelial infiltrates that can impair visual acuity
- nih.gov
Clinically and pathophysiologically, it features conjunctival hyperemia, chemosis, ocular pain, foreign-body sensation, and photophobia, accompanied by corneal epithelial disruption ranging from superficial punctate keratitis to stromal ulceration or subepithelial infiltrates that can impair visual acuity
- nih.gov
Clinically and pathophysiologically, it features conjunctival hyperemia, chemosis, ocular pain, foreign-body sensation, and photophobia, accompanied by corneal epithelial disruption ranging from superficial punctate keratitis to stromal ulceration or subepithelial infiltrates that can impair visual acuity
Personalize your experience
Follow Keratoconjunctivitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.